A recent study, published in the journal Neurology, assessed foetal risk after pregnancy exposure to natalizumab (Tysabri) in women with multiple sclerosis (MS). The Italian study specifically focused on spontaneous abortion and congenital anomalies…Read more - http://www.ms-uk.org/study-reveals-risk ... -pregnancy
